Guest guest Posted September 14, 1998 Report Share Posted September 14, 1998 Hope you guys don't mind...I'm just going through old mail and sending things are are interesting!! > >> " Powderject, Glaxo in Hepatitis Pact " >> Reuters (03/04/98) >> A collaborative agreement reached on Wednesday between >> Powderject Pharmaceuticals and Glaxo Wellcome to develop DNA >> vaccines could become the largest drug research and development >> collaborative agreement in Europe. Under the terms of the >> agreement, Glaxo received the exclusive worldwide rights to use >> Powderject's dry drug delivery technology to commercialize >> vaccines, starting with a Hepatitis B vaccine that is now in >> Phase I clinical trials. Furthermore, Glaxo will invest $20 >> million in Powderject through a purchase of 7.71 percent of the >> company, make an initial $4 million payment for license fee for >> the Hepatitis B vaccine, fund the cost of research and >> development and clinical trials, and pay royalties and other >> milestone payments. The agreement also covers the development of >> DNA vaccines for HIV, cancer, and six other therapeutics not >> specified. >- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.